CHAMPIONS ONCOLOGY, INC. Increase (Decrease) in Deferred Revenue
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Increase (Decrease) in Deferred Revenue of $1.71 million for the 12-month period ending 2023-04-30, per its 10-K filed 2023-07-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2023-07-24
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in deferred revenue for the quarter ending 2019-04-30 was -$701.00K, a 182.18% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in deferred revenue for the quarter ending 2019-01-31 was -$105.00K.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in deferred revenue for the quarter ending 2018-10-31 was $565.00K, a 297.89% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in deferred revenue for the quarter ending 2018-07-31 was -$441.00K.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in deferred revenue for fiscal 2023 was $1.71M, a 64.57% decline from fiscal 2022.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in deferred revenue for fiscal 2022 was $4.82M, a 991.84% increase from fiscal 2021.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in deferred revenue for fiscal 2021 was $441.00K, a 75.39% decline from fiscal 2020.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in deferred revenue for fiscal 2020 was $1.79M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2023-04-30 | $1.71M 10-K · filed 2023-07-24 | |||
| 2022-04-30 | $4.82M 10-K · filed 2023-07-24 | |||
| 2021-04-30 | $441.00K 10-K · filed 2022-07-22 | |||
| 2020-04-30 | $1.79M 10-K · filed 2021-07-26 | |||
| 2019-04-30 | -$701.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | -$806.00K derived: sum of 2 quarters · filed 2020-07-28 | -$241.00K derived: sum of 3 quarters · filed 2020-07-28 | -$682.00K 10-K · filed 2020-07-28 |
| 2019-01-31 | -$105.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | $460.00K derived: sum of 2 quarters · filed 2019-03-18 | $19.00K 10-Q · filed 2019-03-18 | $872.00K derived: sum of 4 quarters · filed 2019-07-29 |
| 2018-10-31 | $565.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-17 | $124.00K 10-Q · filed 2018-12-17 | $977.00K derived: sum of 3 quarters · filed 2019-07-29 | $949.00K derived: sum of 4 quarters · filed 2019-07-29 |
| 2018-07-31 | -$441.00K 10-Q · filed 2018-09-14 | $412.00K derived: sum of 2 quarters · filed 2019-07-29 | $384.00K derived: sum of 3 quarters · filed 2019-07-29 | $526.00K derived: sum of 4 quarters · filed 2019-07-29 |
| 2018-04-30 | $853.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29 | $825.00K derived: sum of 2 quarters · filed 2019-07-29 | $967.00K derived: sum of 3 quarters · filed 2019-07-29 | -$206.00K 10-K · filed 2019-07-29 |
| 2018-01-31 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | $114.00K derived: sum of 2 quarters · filed 2019-03-18 | -$1.06M 10-Q · filed 2019-03-18 | $229.00K derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-10-31 | $142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-17 | -$1.03M 10-Q · filed 2018-12-17 | $257.00K derived: sum of 3 quarters · filed 2018-12-17 | $735.00K derived: sum of 4 quarters · filed 2018-12-17 |
| 2017-07-31 | -$1.17M 10-Q · filed 2018-09-14 | $115.00K derived: sum of 2 quarters · filed 2018-09-14 | $593.00K derived: sum of 3 quarters · filed 2018-09-14 | $1.04M derived: sum of 4 quarters · filed 2018-09-14 |
| 2017-04-30 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | $1.77M derived: sum of 2 quarters · filed 2018-07-30 | $2.21M derived: sum of 3 quarters · filed 2018-07-30 | $1.77M 10-K · filed 2018-07-30 |
| 2017-01-31 | $478.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $925.00K derived: sum of 2 quarters · filed 2018-03-19 | $483.00K 10-Q · filed 2018-03-19 | $747.00K derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-10-31 | $447.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | $5.00K 10-Q · filed 2017-12-15 | $269.00K derived: sum of 3 quarters · filed 2017-12-15 | $1.50M derived: sum of 4 quarters · filed 2017-12-15 |
| 2016-07-31 | -$442.00K 10-Q · filed 2017-09-14 | -$178.00K derived: sum of 2 quarters · filed 2017-09-14 | $1.05M derived: sum of 3 quarters · filed 2017-09-14 | $790.00K derived: sum of 4 quarters · filed 2017-09-14 |
| 2016-04-30 | $264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $1.50M derived: sum of 2 quarters · filed 2017-07-28 | $1.23M derived: sum of 3 quarters · filed 2017-07-28 | $1.13M 10-K · filed 2017-07-28 |
| 2016-01-31 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | $968.00K derived: sum of 2 quarters · filed 2017-03-17 | $866.00K 10-Q · filed 2017-03-17 | $566.00K derived: sum of 4 quarters · filed 2017-03-17 |
| 2015-10-31 | -$265.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | -$367.00K 10-Q · filed 2016-12-14 | -$667.00K derived: sum of 3 quarters · filed 2016-12-14 | -$118.00K derived: sum of 4 quarters · filed 2016-12-14 |
| 2015-07-31 | -$102.00K 10-Q · filed 2016-09-14 | -$402.00K derived: sum of 2 quarters · filed 2016-09-14 | $147.00K derived: sum of 3 quarters · filed 2016-09-14 | $243.00K derived: sum of 4 quarters · filed 2016-09-14 |
| 2015-04-30 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $249.00K derived: sum of 2 quarters · filed 2016-07-29 | $345.00K derived: sum of 3 quarters · filed 2016-07-29 | -$82.00K 10-K · filed 2016-07-29 |
| 2015-01-31 | $549.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | $645.00K derived: sum of 2 quarters · filed 2016-03-16 | $218.00K 10-Q · filed 2016-03-16 | $214.00K derived: sum of 4 quarters · filed 2016-03-16 |
| 2014-10-31 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-15 | -$331.00K 10-Q · filed 2015-12-15 | -$335.00K derived: sum of 3 quarters · filed 2015-12-15 | -$199.00K derived: sum of 4 quarters · filed 2015-12-15 |
| 2014-07-31 | -$427.00K 10-Q · filed 2015-09-11 | -$431.00K derived: sum of 2 quarters · filed 2015-09-11 | -$295.00K derived: sum of 3 quarters · filed 2015-09-11 | $804.00K derived: sum of 4 quarters · filed 2015-09-11 |
| 2014-04-30 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | $132.00K derived: sum of 2 quarters · filed 2015-07-29 | $1.23M derived: sum of 3 quarters · filed 2015-07-29 | $977.00K 10-K · filed 2015-07-29 |
| 2014-01-31 | $136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $1.24M derived: sum of 2 quarters · filed 2015-03-17 | $981.00K 10-Q · filed 2015-03-17 | $1.08M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-10-31 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $845.00K 10-Q · filed 2014-12-15 | $942.00K derived: sum of 3 quarters · filed 2014-12-15 | $754.00K derived: sum of 4 quarters · filed 2014-12-15 |
| 2013-07-31 | -$254.00K 10-Q · filed 2014-09-12 | -$157.00K derived: sum of 2 quarters · filed 2014-09-12 | -$345.00K derived: sum of 3 quarters · filed 2014-09-12 | -$58.00K derived: sum of 4 quarters · filed 2014-09-12 |
| 2013-04-30 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28 | -$91.00K derived: sum of 2 quarters · filed 2014-07-28 | $196.00K derived: sum of 3 quarters · filed 2014-07-28 | -$71.00K 10-K · filed 2014-07-28 |
| 2013-01-31 | -$188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-14 | $99.00K derived: sum of 2 quarters · filed 2014-03-14 | -$168.00K 10-Q · filed 2014-03-14 | -$484.00K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-10-31 | $287.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-13 | $20.00K 10-Q · filed 2013-12-13 | -$296.00K derived: sum of 3 quarters · filed 2013-12-13 | -$694.00K derived: sum of 4 quarters · filed 2013-12-13 |
| 2012-07-31 | -$267.00K 10-Q · filed 2013-09-13 | -$583.00K derived: sum of 2 quarters · filed 2013-09-13 | -$981.00K derived: sum of 3 quarters · filed 2013-09-13 | -$1.16M derived: sum of 4 quarters · filed 2013-09-13 |
| 2012-04-30 | -$316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26 | -$714.00K derived: sum of 2 quarters · filed 2013-07-26 | -$892.00K derived: sum of 3 quarters · filed 2013-07-26 | -$433.00K 10-K · filed 2013-07-26 |
| 2012-01-31 | -$398.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-13 | -$576.00K derived: sum of 2 quarters · filed 2013-03-13 | -$117.00K 10-Q · filed 2013-03-13 | $1.13M derived: sum of 4 quarters · filed 2013-03-13 |
| 2011-10-31 | -$178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-13 | $281.00K 10-Q · filed 2012-12-13 | $1.53M derived: sum of 3 quarters · filed 2012-12-13 | $1.31M derived: sum of 4 quarters · filed 2012-12-13 |
| 2011-07-31 | $459.00K 10-Q · filed 2012-09-12 | $1.71M derived: sum of 2 quarters · filed 2012-09-12 | $1.49M derived: sum of 3 quarters · filed 2012-09-12 | $1.51M derived: sum of 4 quarters · filed 2012-09-12 |
| 2011-04-30 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-18 | $1.03M derived: sum of 2 quarters · filed 2012-07-18 | $1.05M derived: sum of 3 quarters · filed 2012-07-18 | $697.00K 10-K · filed 2012-07-18 |
| 2011-01-31 | -$214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-14 | -$195.00K derived: sum of 2 quarters · filed 2012-03-14 | -$550.00K 10-Q · filed 2012-03-14 | |
| 2010-10-31 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-14 | -$336.00K 10-Q · filed 2011-12-14 | ||
| 2010-07-31 | -$355.00K 10-Q · filed 2011-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |